Argitalpenak (11) Amanda De la Fuente Vázquez argitalpenak

2024

  1. Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19

    International Journal of Infectious Diseases, Vol. 140, pp. 132-135

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  2. Prime-time for clinical use of transcriptomics for differentiating viral from bacterial respiratory infection

    European Journal of Clinical Investigation

2022

  1. Digital PCR applications for the diagnosis and management of infection in critical care medicine

    Critical Care, Vol. 26, Núm. 1

  2. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  3. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5

2021

  1. A host transcriptomic signature for identification of respiratory viral infections in the community

    European Journal of Clinical Investigation, Vol. 51, Núm. 12

  2. Combining immunomodulators and antivirals for COVID-19 – Authors' reply

    The Lancet Microbe

  3. Mounting evidence of impaired viral control in severe COVID-19

    The Lancet Microbe

  4. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

    The Lancet Respiratory Medicine, Vol. 9, Núm. 6, pp. 622-642

2020

  1. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1